Halozyme Therapeutics HALO
NASDAQ HALO
$110.43 -1.13 (-1.01%)
As of: Sep 30, 2026 · 3:59 PM EDT

Halozyme Therapeutics (HALO) Total Current Liabilities (2010 - 2026)

Updated

Halozyme Therapeutics (HALO) posted Total Current Liabilities of $344.44 million for Q2 2026, up 156.5% from $134.28 million a year earlier but down 5.2% from the prior quarter.

Analysis

Halozyme Therapeutics (HALO) Total Current Liabilities (2010 - 2026) Analysis & Trends

At the end of FY2025, Halozyme Therapeutics' Total Current Liabilities came in at $177.09 million, up 27.3% from FY2024.

  • Annual Total Current Liabilities shows a five-year compound annual growth rate of -15.9% (FY2020 to FY2025).
  • In prior years, Halozyme Therapeutics' Total Current Liabilities was $139.1 million in FY2024 (+23.7%), $112.49 million in FY2023 (-14.0%), $130.79 million in FY2022 (+11.6%) and $117.15 million in FY2021 (-72.2%).
  • Quarterly Total Current Liabilities has run from a low of $91.92 million in Q1 2023 to a high of $837.23 million in Q3 2025 over five years.
  • On a year-over-year basis, Total Current Liabilities has increased in each of the last seven quarters, with growth averaging 128.5% over the last eight quarters.
  • The strongest year-over-year quarter for Total Current Liabilities in the past five years was Q3 2025, with growth of 669.4%; the weakest was Q4 2021, with a decline of 72.2%.
  • According to Business Quant data, Total Current Liabilities for the three prior quarters was $363.21 million (Q1 2026), $177.09 million (Q4 2025) and $837.23 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 54.90 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 41.64 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -31.55 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 3.94 Bn
10 Halozyme Therapeutics 12.72 Bn 11.33 Bn 401.83 Mn 344.44 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 344.44 Mn
Mar 31, 2026 363.21 Mn
Dec 31, 2025 177.09 Mn
Sep 30, 2025 837.23 Mn
Jun 30, 2025 134.28 Mn
Mar 31, 2025 150.38 Mn
Dec 31, 2024 139.10 Mn
Sep 30, 2024 108.82 Mn
Jun 30, 2024 133.36 Mn
Mar 31, 2024 131.64 Mn
Dec 31, 2023 112.49 Mn
Sep 30, 2023 115.19 Mn
Jun 30, 2023 116.39 Mn
Mar 31, 2023 91.92 Mn
Dec 31, 2022 130.79 Mn
Sep 30, 2022 109.38 Mn
Jun 30, 2022 199.51 Mn
Mar 31, 2022 111.69 Mn
Dec 31, 2021 117.15 Mn
Sep 30, 2021 113.15 Mn
API Access

Halozyme Therapeutics Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=HALO&period=max&api_key=YOUR_API_KEY